Tag: NovoCure

NovoCure (Nasdaq: NVCR), a developer of cancer treatments by focusing electric fields on the growth, reported $184 million revenue ...

Novocure (Nasdaq: NVCR), developer of a technology for treating cancer by means of electric fields, announced today that the ...